Healthcare
Live Price
Offline$0.013
+0.00% today
1Y Change
-75.47%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vincerx Pharma, Inc. (VINC) is a Healthcare stock with listed on OTC. The stock last traded around $0.01 and down 75.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +15.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +15.9%, free cash flow +35.4% with operating margin -1138.6% and ROIC -588.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Stock Foundry combines VINC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VINC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VINC Max Drawdown
-92.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VINC and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.